In this study, we propose the use of iron oxide nanoparticle encapsulated with peptide-conjugated poly͑D,L lactide-co-glycolide͒ ͑PLGA͒ as a potent intracellular carrier for diagnosis agent. The iron oxide ͑␥-Fe 2 O 3 ͒ nanoparticles were prepared by a chemical coprecipitation method of ferric and ferrous ions in an alkali solution. Arg peptide ͑RRRRRRRRCK-FITC͒ were conjugated to the PLGA via a simple coupling reaction between maleimide-derivatized PLGA and thiol-terminated Arg peptide. The ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticle was then prepared by an emulsification-diffusion technique. A confocal laser scanning microscopy revealed that the ␥ -Fe 2 O 3 -PLGA-Arg-FITC nanoparticle was effectively adsorbed onto the membrane of stem cells and delivered into the nuclei without cytotoxicity. Magnetic properties of the ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticle were observed by measuring the zero-field-cooled/ field-cooled magnetization and magnetic hysteresis loop using a superconducting quantum interference device magnetometer from 5 K to 300 K.
I. INTRODUCTION
In recent years, superparamagnetic nanoparticles have been evaluated as magnetic resonance ͑MR͒ molecular imaging contrast agent, especially for liver, spleen, and breast. MR imaging is a noninvasive technique routinely used clinically for diagnostic imaging. However, intrinsic sensitivity of MR technique is significantly low in comparison with conventional optical and nuclear imaging. Therefore, to improve the sensitivity of MR up to the level where detection of molecular markers becomes possible, special contrast agents amplifying the MR signals need to be designed. Significant signal amplification can be achieved if the contrast agent is allowed to accumulate in the target cells by passive endocytosis, or by an active transporter system such as a transferrin receptor that shuttles targeted contrast agent into the cell. Therefore, the development of superparamagnetic iron oxide nanoparticles and iron oxide nanoparticles encapsulated have been intensively pursued because of their technological and fundamental scientific importance.
1,2 Superparamagnetic nanoparticles offer a high potential for several applications in different areas such as ferrofluids, color imaging, magnetic refrigeration, detoxification of biological fluids, magnetically controlled transport of anticancer drugs, magnetic resonance imaging contrast enhancement and magnetic cell separation. 3, 4 In this study, we propose here the use of peptides-conjugated magnetic nanoparticles as a potent intracellular carrier for MR molecular image diagnosis agent.
II. EXPERIMENT
Superparamagnetic nanoparticles of maghemite ͑␥-Fe 2 O 3 ͒ were prepared by a chemical coprecipitation method of ferric and ferrous ions in alkali solution. The detailed procedure was described in a previous report. 4 The reaction steps in our process are as follows:
A molar ratio of Fe͑II͒ /Fe͑III͒ = 0.5 was dissolved in water with sonication. The resulting solution was poured with piezoelectric nozzle ͑nozzle size: 50 m, 5 ϫ 10 −7 ml/ drop͒ method into an alkali solution. The x-ray diffraction ͑XRD͒ pattern matches well with that of ␥-Fe 2 O 3 ͑powder diffraction file, JCPOS card no. 25-1402͒. All organic solvents used in this experiments were either high performance liquid chromatography ͑HPLC͒ grade or american chemical society analytical grade reagents.
In Fig. 1͑a͒ , we demonstrate procedure for preparing the iron oxide ͑␥-Fe 2 O 3 ͒ nanoparticles encapsulated with Arginine ͑Arg͒ peptide ͑RRRRRRRRCK-FITC͒ conjugated with poly ͑D,L lactide-co-glycolide͒ ͑PLGA͒. It should be noted that Arg peptide is well known as a cell penetration peptide. Cell penetration peptide means peptides leaded to intracellu-lar translocation across the cellular membrane into the cytoplasm and nucleus by a seemingly energy-independent mechanism.
5,6 Figure 1͑b͒ shows the sequence of Arg peptide. The fluorescein ͑FITC͒ conjugated Arg peptide was prepared by Peptron ͑Daejeon, Korea͒. The FITC was conjugated to observe the intracellular translocation of magnetic nanoparticles into the cell. The Arg peptide was synthesized by solid phase peptide synthesis and purified ͑Ͼ95% ͒ by using reverse-phase HPLC, and their molecular masses were determined by mass spectroscopy. The intracellular translocation was investigated using the human mesenchymal stem cells ͑MSC͒, obtained from Yonsei medical center.
The cellular internalization into MSC was examined by using a confocal laser scanning microscope ͑CLSM͒. XRD measurement using Cu K␣ radiation was performed to identify the crystal structure of iron oxide nanoparticles. Magnetization measurements were performed using a superconducting quantum interference device ͑SQUID͒ magnetometer from 5 K to 300 K.
III. RESULTS AND DISCUSSION
To encapsulate the magnetic nanoparticle using peptideconjugated PLGA, we first combined FITC conjugated Arg peptide with PLGA. The Arg peptide was conjugated to PLGA via a simple coupling reaction between maleimidederivatized PLGA and thiol-terminated Arg peptide. Carboxylic acid end group of PLGA was activated to the succinimidyl ester using N-hydroxysuccinimide and 1,3-dicyclohexylcarbodiimide, and then, was converted to primary amine groups using an excess amount of hexamethylene diamine. Maleimide-terminated PLGA was then prepared by reacting N-succinimidyl 4-͑4-maleeimidophenyl͒ butyrate to the primary amine terminated PLGA. Finally, PLGA was conjugated to the Arg peptide by the coupling reaction between maleimide group of PLGA and the sulfhydryl group of the Arg peptide. The resulting Arg peptide conjugated PLGA was purified by dialysis against excess de-ionized distilled water and freeze drying.
After preparing the Arg-peptide conjugated PLGA, the ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles were prepared by using an emulsification-diffusion method.
2 First, 200 mg of peptide-conjugated PLGA was dissolved in 10 ml of ethylacetate ͑EtAc, Fluka͒ forming 2 wt % of polymer solution, and then 60 mg of magnetic nanoparticle was added. The mixture was emulsified for 5 min with a bath-type sonicator. The organic mixture with magnetic nanoparticle was added into 20 ml of an aqueous phase containing stabilizer. After mutual saturation of organic and continuous phases, the mixture was emulsified for 7 min with a high speed homogenizer ͑about 20 000 rpm͒, and then water is added to o / w emulsion solution under sonicator. The subsequent addition of water dilutes the solvent concentration and it causes extraction of solvent from the polymer solution, which leads to the nanoprecipitation of polymer. The conjugation degree of the Arg peptides at the surface of ␥-Fe 2 O 3 was about 18.7% in EtAc, as determined by a UV absorbance ͓UV absorbance = ϫconcentration͑M͒ ϫ length of the UV cell ͑cm͒, = 80 000M −1 cm −1 ͔ where is molecular extinction coefficient of the FITC.
7 Figure 2 shows the size distribution of ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles measured by dynamic light scattering ͑DLS͒. As seen in Fig. 2 , it shows very narrow size distribution from 111 nm to 116 nm, which is very suitable for intercellular application.
To investigate the magnetic properties of the ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles, ͑field-cooled/zerofield-cooled͒ ͑FC/ZFC͒ measurements have been made using a SQUID magnetometer. The SQUID measurements revealed superparamagnetic nature of the ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles. Figure  3 shows the FC and ZFC curves for the 115 nm ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles from 5 K to 300 K at 200 Oe. The ZFC and FC curves coincide above 180 K and separate below 180 K. The ZFC curve shows a broad peak at T max ϳ 102± 5 K indicative of a characteristic blocking temperature for superparamagnetic particles. [8] [9] [10] [11] To investigate the intracellular translocation of the ␥ -Fe 2 O 3 -PLGA-Arg-FITC nanoparticles, the MSC were cultured in Dulbecco's modified eagle medium ͑DMEM, Gibco shows that the ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles were effectively adsorbed onto the membrane of stem cells and delivered into the nuclei. To verify this phenomena, the iron oxide nanoparticles were stained with prussian blue dye called Fe dye, ferric ferrocyanide, Fe 4 ͓Fe͑CN͒ 6 ͔ 3 , at about 200 g/ml of ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles concentration. As shown in Fig. 4͑b͒ , the optical microscope image for prussian blue staining Fe elements clearly represent that the ␥-Fe 2 O 3 -PLGA-Arg-FITC nanoparticles have superior intracellular translocation ability into the cell. The intracellular blue color in Fig. 4͑b͒ shows the iron oxide nanoparticles which are transferred into the stem cell, i.e., most of iron oxide nanoparticles effectively accumulated, adsorbed onto the membrane of stem cells, and delivered into the nuclei in the cell. Cytotoxicity of intracellular carriers is one of the most important parameters to be checked. To deal with this concern, cytotoxicity was checked using a 3,4,5-dimethylthiazol-2-yl-2,5-diphenyl tetrazolium bromide ͑MTT, Sigma͒ assay and a lactate dehydrogenase ͑CytoTox 96 kit, Promega, Madison, USA͒ release assay. In this test, two-day cell incubation with peptide-conjugated ␥-Fe 2 O 3 -PLGA-Arg did not show significant cytotoxicity up to 200 g / ml of iron oxide nanoparticle concentration.
IV. CONCLUSIONS
The ␥- 
